Dorsey Wright & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Sell
19,191
-8,252
-30% -$1.92M 0.83% 40
2026
Q1
$6.71M Buy
27,443
+8,953
+48% +$2.09M 0.83% 42
2025
Q4
$3.83M Buy
+18,490
New +$3.66M 0.83% 40

Other funds holding JNJ

Dorsey Wright & Associates's JNJ Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Johnson & Johnson (JNJ) stake by 30% in Q2 2026, selling an estimated $1.92M and leaving 19,191 shares worth $4.87M. The position accounts for 0.83% of the portfolio, ranked #40.

Dorsey Wright & Associates first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.71M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Dorsey Wright & Associates held 19,191 shares of Johnson & Johnson worth $4.87M as of Q2 2026.
  • Dorsey Wright & Associates sold 8,252 Johnson & Johnson shares in Q2 2026, an estimated $1.92M.
  • Johnson & Johnson made up 0.83% of Dorsey Wright & Associates's portfolio in Q2 2026, its #40 holding.
  • Dorsey Wright & Associates first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Dorsey Wright & Associates's Johnson & Johnson position peaked at $6.71M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.